King's College Hospital Criteria for non-acetaminophen induced acute liver failure in an international cohort of children.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 3504621)

Published in J Pediatr on August 18, 2012

Authors

Vinay Sundaram1, Benjamin L Shneider, Anil Dhawan, Vicky L Ng, Kyungah Im, Steven Belle, Robert H Squires

Author Affiliations

1: Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. vsundaram@llu.edu

Articles cited by this

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med (2002) 11.38

Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43

AASLD position paper: the management of acute liver failure. Hepatology (2005) 5.09

Acute liver failure. N Engl J Med (1993) 3.81

Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr (2006) 3.03

Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children. J Pediatr (1998) 3.02

MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl (2007) 1.94

Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl (2000) 1.88

Fulminant hepatic failure in childhood: an analysis of 31 cases. Arch Dis Child (1980) 1.53

Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology (1998) 1.48

Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost (2007) 1.34

Acute liver failure in infancy: a 14-year experience of a pediatric liver transplantation center. J Pediatr (2001) 1.22

Characterization of acute liver failure and development of a continuous risk of death staging system in children. J Hepatol (2005) 1.20

Fulminant hepatic failure secondary to acetaminophen poisoning: a systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med (2003) 1.19

Acute liver failure in children. Semin Liver Dis (2008) 1.14

Delayed encephalopathy in fulminant hepatic failure in the pediatric population and the role of liver transplantation. J Pediatr Gastroenterol Nutr (1997) 1.11

Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. J Hepatol (1997) 1.04

Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant (2007) 1.03

Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology (1992) 1.03

Acute liver failure in children: A regional experience. J Paediatr Child Health (2003) 1.02

Prognosis for neonates with enterovirus hepatitis and coagulopathy. Pediatr Infect Dis J (2001) 1.02

Prognostic factors in paediatric acute liver failure. Arch Dis Child (2007) 1.01

Improving long-term outcomes after liver transplantation in children. Am J Transplant (2008) 0.96

Fatal coxsackievirus B infection in early infancy characterized by fulminant hepatitis. J Infect (1998) 0.92

Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure. Semin Liver Dis (2003) 0.91

Fulminant hepatic failure. J Pediatr (1987) 0.85

The immunological monitoring of kidney and liver transplants in adult and pediatric recipients. Transpl Immunol (2009) 0.80

Glycine conjugation of para-aminobenzoic acid (PABA): a pilot study of a novel prognostic test in acute liver failure in children. J Pediatr Gastroenterol Nutr (2003) 0.79

Neonatal liver transplantation for fulminant hepatitis caused by herpes simplex virus type 2. J Pediatr Gastroenterol Nutr (2002) 0.77

Articles by these authors

Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med (2015) 8.69

Acute liver failure: Summary of a workshop. Hepatology (2008) 3.49

Acute liver failure. Lancet (2010) 3.39

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet (2014) 3.12

Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology (2008) 3.04

Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr (2006) 3.03

Detection of acetaminophen protein adducts in children with acute liver failure of indeterminate cause. Pediatrics (2006) 2.96

Patients' recollections of stressful experiences while receiving prolonged mechanical ventilation in an intensive care unit. Crit Care Med (2002) 2.91

Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J Pediatr (2009) 2.46

Coordinate expression of regulatory genes differentiates embryonic and perinatal forms of biliary atresia. Hepatology (2004) 2.28

The relationship between convenience of destinations and walking levels in older women. Am J Health Promot (2003) 2.00

Baseline Analysis of a Young α-1-Antitrypsin Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension. J Pediatr Gastroenterol Nutr (2015) 1.98

Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure. Liver Transpl (2008) 1.97

Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology (2008) 1.95

Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr (2012) 1.91

The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor. Hepatology (2008) 1.90

Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT. Nat Genet (2003) 1.85

Chronic abdominal pain in children: a clinical report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr (2005) 1.81

Extrahepatic anomalies in infants with biliary atresia: results of a large prospective North American multicenter study. Hepatology (2013) 1.80

Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology (2013) 1.78

A critical review of the health-related quality of life of children and adolescents after liver transplantation. Liver Transpl (2005) 1.75

Growth failure and outcomes in infants with biliary atresia: a report from the Biliary Atresia Research Consortium. Hepatology (2007) 1.68

One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation (2004) 1.62

Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up. J Hepatol (2009) 1.61

Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter. J Biol Chem (2002) 1.60

Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range. Liver Transpl (2004) 1.58

A genetic study of Wilson's disease in the United Kingdom. Brain (2013) 1.53

Chronic Abdominal Pain In Children: a Technical Report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr (2005) 1.51

Parents and clinicians underestimate distress and depression in children who had a transplant. Pediatr Transplant (2005) 1.50

Portal hypertension in children: expert pediatric opinion on the report of the Baveno v Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension. Pediatr Transplant (2012) 1.49

Aetiology and management of extrahepatic portal vein obstruction in children: King's College Hospital experience. J Pediatr Gastroenterol Nutr (2008) 1.48

Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl (2005) 1.47

Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure. J Pediatr Gastroenterol Nutr (2007) 1.47

Resolution of hepatopulmonary syndrome after auxiliary partial orthotopic liver transplantation in Abernethy malformation. A case report. Liver Transpl (2007) 1.46

Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids. Am J Physiol Gastrointest Liver Physiol (2005) 1.45

Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics (2004) 1.44

Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia. J Hepatol (2005) 1.44

Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children. J Hepatol (2007) 1.44

Assessing nutritional status in children with chronic liver disease. J Gastroenterol Hepatol (2005) 1.43

Human ITCH E3 ubiquitin ligase deficiency causes syndromic multisystem autoimmune disease. Am J Hum Genet (2010) 1.43

Scurvy diagnosed in a pediatric liver transplant patient awaiting combined kidney and liver retransplantation. Pediatr Transplant (2008) 1.42

Liver transplantation for children with biliary atresia in the pediatric end-stage liver disease era: the role of insurance status. Liver Transpl (2013) 1.42

Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology (2004) 1.41

Barriers to the successful treatment of liver disease by hepatocyte transplantation. J Hepatol (2010) 1.41

Utility of azathioprine metabolite measurements in post-transplant recurrent autoimmune and immune-mediated hepatitis. Pediatr Transplant (2004) 1.39

Primary sclerosing cholangitis: summary of a workshop. Hepatology (2006) 1.38

Is single-port laparoscopy feasible after liver transplant? Pediatr Transplant (2013) 1.37

Bile acid-induced negative feedback regulation of the human ileal bile acid transporter. Hepatology (2004) 1.36

Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant (2012) 1.31

Current status of hepatocyte transplantation. Transplantation (2012) 1.28

Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference. J Pediatr (2006) 1.26

Translational systems approaches to the biology of inflammation and healing. Immunopharmacol Immunotoxicol (2010) 1.18

Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review. J Pediatr Gastroenterol Nutr (2009) 1.17

beta-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes. Am J Physiol Gastrointest Liver Physiol (2008) 1.15

Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis. J Biol Chem (2003) 1.15

Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD. J Pediatr Gastroenterol Nutr (2010) 1.13

Update on progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr (2008) 1.12

Comparison of parent and child reports of emotional trauma symptoms in pediatric outpatient settings. Pediatrics (2005) 1.11

Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation. Liver Transpl (2006) 1.10

Solitary Hepatic Nodule Adjacent to the Right Portal Vein: A Common Finding of Alagille Syndrome? J Pediatr Gastroenterol Nutr (2016) 1.10

Intraportal transplantation of human bone marrow mesenchymal stem cells in pigs with fulminant hepatic failure. Hepatology (2013) 1.09

Optimization of the cryopreservation and thawing protocol for human hepatocytes for use in cell transplantation. Liver Transpl (2010) 1.07

Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome. Clin J Am Soc Nephrol (2008) 1.06

Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children. Pediatr Transplant (2010) 1.05

Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy. Gastroenterology (2003) 1.05

Analysis of serum inflammatory mediators identifies unique dynamic networks associated with death and spontaneous survival in pediatric acute liver failure. PLoS One (2013) 1.04

Intrahepatic cholestasis: summary of an American Association for the Study of Liver Diseases single-topic conference. Hepatology (2005) 1.04

Predominant extrahepatic biliary disease in autosomal recessive polycystic kidney disease: a new association. Pediatr Transplant (2006) 1.02

A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migration. J Hepatol (2011) 1.00

Symptoms of posttraumatic stress disorder in patients who have had a myocardial infarction. Psychosomatics (2006) 1.00

Human hepatocyte isolation and relationship of cell viability to early graft function. Cell Transplant (2003) 1.00

MR cholangiography in the evaluation of neonatal cholestasis: initial results. Radiology (2002) 1.00

FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade. Am J Physiol Gastrointest Liver Physiol (2005) 0.99

The instant blood-mediated inflammatory reaction characterized in hepatocyte transplantation. Transplantation (2011) 0.99

Auxiliary liver transplantation for acute liver failure in children. Ann Surg (2010) 0.98

Characterization and outcomes of young infants with acute liver failure. J Pediatr (2011) 0.98

Guidance for clinical trials for children and adolescents with chronic hepatitis C. J Pediatr Gastroenterol Nutr (2011) 0.97

Neonatal herpes simplex virus infection presenting as acute liver failure: prevalent role of herpes simplex virus type I. J Pediatr Gastroenterol Nutr (2006) 0.96

Results of split liver transplantation in children. Ann Surg (2002) 0.96

Transient elastography is a useful noninvasive tool for the evaluation of fibrosis in paediatric chronic liver disease. J Pediatr Gastroenterol Nutr (2013) 0.96

Relationship of adiposity to subclinical atherosclerosis in obese patients with type 2 diabetes. Obes Res (2003) 0.94

Congenital hepatic fibrosis and autosomal recessive polycystic kidney disease. J Pediatr Gastroenterol Nutr (2012) 0.94

Novel fibrinogen gamma375 Arg-->Trp mutation (fibrinogen aguadilla) causes hepatic endoplasmic reticulum storage and hypofibrinogenemia. Hepatology (2002) 0.94

Auxiliary transplantation for acute liver failure: Histopathological study of native liver regeneration. Liver Transpl (2008) 0.94

Evaluation of the child with suspected mitochondrial liver disease. J Pediatr Gastroenterol Nutr (2013) 0.93

Acute liver failure in children. Clin Liver Dis (2006) 0.93

Inhibition of human m-epoxide hydrolase gene expression in a case of hypercholanemia. Biochim Biophys Acta (2003) 0.93

Use of a clinically approved iron oxide MRI contrast agent to label human hepatocytes. Cell Transplant (2010) 0.92

Biliary atresia with associated structural malformations in Canadian infants. Liver Int (2011) 0.92

Progress in human hepatocytes: isolation, culture & cryopreservation. Semin Cell Dev Biol (2002) 0.92

Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr (2017) 0.91

Cryopreservation-induced nonattachment of human hepatocytes: role of adhesion molecules. Cell Transplant (2007) 0.91

Hepatitis C in children: a quaternary referral center perspective. J Pediatr Gastroenterol Nutr (2006) 0.90

The SPLIT research agenda 2013. Pediatr Transplant (2013) 0.90

c-Fos is a critical mediator of inflammatory-mediated repression of the apical sodium-dependent bile acid transporter. Gastroenterology (2006) 0.90

Human hepatocyte transplantation overview. Methods Mol Biol (2009) 0.90